Hersh V Gupta
Affiliations: | Broad Institute - Cancer Program |
Area:
cancer biologyGoogle:
"https://scholar.google.com/citations?user=pnPzLqMAAAAJ&hl=en"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| John D. Chodera | research assistant | 2017-2020 | Memorial Sloan Kettering Cancer Center |
| Brenda M. Rubenstein | research assistant | 2017-2020 | Brown |
| Andrew D. Cherniack | research assistant | 2020-2022 | Broad Institute |
| Matthew Meyerson | research assistant | 2020-2022 | (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Singh H, Sahgal P, Kapner K, et al. (2024) RAS/RAF co-mutation and ERBB2 copy number modulates HER2 heterogeneity and responsiveness to HER2-directed therapy in colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Ricciuti B, Lamberti G, Puchala SR, et al. (2024) Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300580 |
| Tarantino P, Gupta H, Hughes ME, et al. (2023) Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature Communications. 14: 8321 |
| Tarantino P, Gupta H, Hughes ME, et al. (2023) Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature Communications. 14: 7496 |
| Groves A, Ward A, Li YY, et al. (2023) Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors. Pediatric Blood & Cancer. e30643 |
| Singh H, Keller RB, Kapner KS, et al. (2023) Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Alessi JV, Wang X, Elkrief A, et al. (2023) Impact of aneuploidy and chromosome 9p loss on tumor immune microenvironment and immune checkpoint inhibitor efficacy in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Ricciuti B, Elkrief A, Alessi J, et al. (2023) Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lazo De La Vega L, Comeau H, Sallan S, et al. (2022) Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. Jco Precision Oncology. 6: e2200390 |
| Church AJ, Corson LB, Kao PC, et al. (2022) Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nature Medicine |